| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |